The practice of packaging infused oncology drugs in “oversized,” single-dose vials leads to significant waste, unnecessarily boosting drug company revenues, according to an article published by Memorial Sloan Kettering Cancer Center’s Peter Bach and others in BMJ March 1.
Based on an analysis of the top 20 cancer drugs that are dosed by body size and packaged in single-dose...